These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26778528)

  • 1. A 96-well microtiter plate assay for high-throughput screening of Mycobacterium tuberculosis dTDP-d-glucose 4,6-dehydratase inhibitors.
    Shi X; Sha S; Liu L; Li X; Ma Y
    Anal Biochem; 2016 Apr; 498():53-8. PubMed ID: 26778528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose.
    Ma Y; Stern RJ; Scherman MS; Vissa VD; Yan W; Jones VC; Zhang F; Franzblau SG; Lewis WH; McNeil MR
    Antimicrob Agents Chemother; 2001 May; 45(5):1407-16. PubMed ID: 11302803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a colorimetric assay and kinetic analysis for Mycobacterium tuberculosis D-glucose-1-phosphate thymidylyltransferase.
    Sha S; Zhou Y; Xin Y; Ma Y
    J Biomol Screen; 2012 Feb; 17(2):252-7. PubMed ID: 21940712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of dTDP-D-Glucose 4,6-dehydratase (RmlB) from Salmonella enterica serovar Typhimurium, the second enzyme in the dTDP-l-rhamnose pathway.
    Allard ST; Giraud MF; Whitfield C; Graninger M; Messner P; Naismith JH
    J Mol Biol; 2001 Mar; 307(1):283-95. PubMed ID: 11243820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The purification, crystallization and structural elucidation of dTDP-D-glucose 4,6-dehydratase (RmlB), the second enzyme of the dTDP-L-rhamnose synthesis pathway from Salmonella enterica serovar typhimurium.
    Allard ST; Giraud MF; Whitfield C; Messner P; Naismith JH
    Acta Crystallogr D Biol Crystallogr; 2000 Feb; 56(Pt 2):222-5. PubMed ID: 10666612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization of natural compounds against mycobacterium tuberculosis 3-dehydroquinate dehydratase: A combined in-silico and in-vitro study.
    Lone MY; Athar M; Gupta VK; Jha PC
    Biochem Biophys Res Commun; 2017 Sep; 491(4):1105-1111. PubMed ID: 28789944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification.
    van der Beek SL; Zorzoli A; Çanak E; Chapman RN; Lucas K; Meyer BH; Evangelopoulos D; de Carvalho LPS; Boons GJ; Dorfmueller HC; van Sorge NM
    Mol Microbiol; 2019 Apr; 111(4):951-964. PubMed ID: 30600561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
    Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
    J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Function of rmlB in the pathogenic Escherichia coli 44277 (O2: k1)].
    Ding W; Luo Y; Ai G; Jin C
    Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1168-76. PubMed ID: 22126071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening for the identification of novel inhibitors of Mycobacterium tuberculosis cell wall synthesis: inhibitors targeting RmlB and RmlC.
    Ren JX; Qian HL; Huang YX; Zhu NY; Si SY; Xie Y
    Comput Biol Med; 2015 Mar; 58():110-7. PubMed ID: 25637777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-and-mechanism-based design and discovery of type II Mycobacterium tuberculosis dehydroquinate dehydratase inhibitors.
    Yao Y; Li ZS
    Curr Top Med Chem; 2014; 14(1):51-63. PubMed ID: 24236726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of mimetics of UDP and UDP-alpha-D-galactose, dTDP and dTDP-alpha-D-glucose with monosaccharides replacing the key pyrophosphate unit.
    Ballell L; Young RJ; Field RA
    Org Biomol Chem; 2005 Mar; 3(6):1109-15. PubMed ID: 15750655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and characterization of dual inhibitors against new targets FabG4 and HtdX of Mycobacterium tuberculosis.
    Banerjee DR; Biswas R; Das AK; Basak A
    Eur J Med Chem; 2015 Jul; 100():223-34. PubMed ID: 26092447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of Mycobacterium tuberculosis type II dehydroquinase inhibitors using a fragment elaboration strategy.
    Tran AT; West NP; Britton WJ; Payne RJ
    ChemMedChem; 2012 Jun; 7(6):1031-43. PubMed ID: 22461418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
    Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C
    J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screen identifies small molecule inhibitors specific for Mycobacterium tuberculosis phosphoserine phosphatase.
    Arora G; Tiwari P; Mandal RS; Gupta A; Sharma D; Saha S; Singh R
    J Biol Chem; 2014 Sep; 289(36):25149-65. PubMed ID: 25037224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enzyme module system for the synthesis of dTDP-activated deoxysugars from dTMP and sucrose.
    Elling L; Rupprath C; Günther N; Römer U; Verseck S; Weingarten P; Dräger G; Kirschning A; Piepersberg W
    Chembiochem; 2005 Aug; 6(8):1423-30. PubMed ID: 15977277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
    Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
    ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.